Editor's Choice: A reinterpretation of SAVR vs TAVR trials

Editor's Choice: A reinterpretation of SAVR v...

Up next

Rebuilding a destroyed heart: the Commando procedure

A pioneer of modern cardiac surgery, Tirone David, joins A Cut Above for a deep dive into one of the specialty's most feared and technically demanding operations: the Commando procedure. Also featuring Eduard Quintana, listen for discussions from radical reconstruction for infect ...  Show more

Valve Therapy in 2026: Is Surgery Losing Ground? A Debate with ESC/EACTS Guideline Co-Authors

In this episode, our hosts are joined by Michael Borger and Nikolaos Bonaros to break down the new valvular heart disease guidelines—what's changed, why it matters, and how the decisions were really made. They cut through the headlines to explain the thinking behind key recommend ...  Show more

Recommended Episodes

Ophthalmology Reviews: A New Frontier in the Ophthalmology Family of Journals
Ophthalmology Journal

Ophthalmology Editor-in-Chief, Russell Van Gelder, MD, PhD, and our new Associate Editor, Laura Downie, BOptom, PhD, guest host this special episode introducing "Ophthalmology Reviews." <span style= "mso-spacerun: yes;"> </span>Ophthalmology Reviews ...

  Show more

PTJ Author Interview: Randomized Clinical Trials and Real-World Practice
APTA Podcasts

In this episode of the PTJ Podcast, Editor-in-Chief Steven George, PT, PhD, FAPTA, talks with Alexander Garbin, PT, DPT, PhD, and Jennifer Stevens-Lapsley, PT, PhD, FAPTA, about their recently published companion papers, which evaluated the effectiveness of a progressive multicom ...  Show more

December 2024: Obstetrics
The Green Room: A Podcast from Obstetrics & Gynecology

A New Podcast from Obstetrics & Gynecology, featuring members from the Editorial Team and contributing authors, each month as they highlight the latest research and practice updates in the field. This episode features an interview with Dr. Naida M. Cole, author of "Second-Line Ut ...  Show more

Evolut Low-Risk Trial: 5-year Data Outcomes
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

Transcatheter aortic valve replacement (TAVR) has emerged as the preferred treatment for aortic stenosis. However, there is a lack of long-term outcome data for low-risk patients. The 5-year results from the Evolut Low-Risk randomized trial address this gap, offering compelling e ...  Show more